SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001731122-24-001965
Filing Date
2024-12-09
Accepted
2024-12-09 17:29:36
Documents
4
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A e6190_def14a.htm DEF 14A 434121
2 GRAPHIC image_001.jpg GRAPHIC 89395
3 GRAPHIC proxy_001.jpg GRAPHIC 960463
4 GRAPHIC proxy_002.jpg GRAPHIC 649205
  Complete submission text file 0001731122-24-001965.txt   2773627
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40064 | Film No.: 241536409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)